ADA-话题@MedSci

#ADA#

386篇内容 | 2939人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1264797, encodeId=6a9e1264e97cf, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=J Headache Pain：丛集性头痛的经济和个人负担, objectType=article, longId=728156, objectId=f665e281567a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f665e281567a, replyNumber=0, likeNumber=42, createdTime=2022-05-31, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f665e281567a, moduleTitle=J Headache Pain：丛集性头痛的经济和个人负担, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f665e281567a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264796, encodeId=2a211264e9686, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=J Headache Pain：头痛的全球患病率, objectType=article, longId=728060, objectId=0a28e2806042, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a28e2806042, replyNumber=0, likeNumber=40, createdTime=2022-05-30, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a28e2806042, moduleTitle=J Headache Pain：头痛的全球患病率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a28e2806042)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264795, encodeId=045d1264e95b7, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=J Headache Pain：致残原因第二，令人炸裂的偏头痛！, objectType=article, longId=726729, objectId=b130e2672931, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b130e2672931, replyNumber=0, likeNumber=42, createdTime=2022-05-14, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b130e2672931, moduleTitle=J Headache Pain：致残原因第二，令人炸裂的偏头痛！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b130e2672931)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264794, encodeId=ea781264e9416, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=Alvotech和STADA与艾伯维解决欧洲专利纠纷，为Humira®的无柠檬酸盐、高浓度生物仿制药HUKYNDRA®(AVT02)上市铺平道路, objectType=article, longId=723787, objectId=0b3be23787cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b3be23787cf, replyNumber=0, likeNumber=36, createdTime=2022-04-09, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b3be23787cf, moduleTitle=Alvotech和STADA与艾伯维解决欧洲专利纠纷，为Humira®的无柠檬酸盐、高浓度生物仿制药HUKYNDRA®(AVT02)上市铺平道路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b3be23787cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264793, encodeId=21001264e933a, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=FDA拒绝批准vadadustat治疗CKD相关贫血, objectType=article, longId=723400, objectId=e743e2340074, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e743e2340074, replyNumber=0, likeNumber=39, createdTime=2022-04-05, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e743e2340074, moduleTitle=FDA拒绝批准vadadustat治疗CKD相关贫血, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e743e2340074)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264792, encodeId=6ccf1264e9234, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=JAMA Dermatol:乌帕替尼（Upadacitinib）治疗中重度特应性皮炎的疗效和安全性, objectType=article, longId=301032, objectId=aa2b30103219, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa2b30103219, replyNumber=0, likeNumber=39, createdTime=2022-03-19, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa2b30103219, moduleTitle=JAMA Dermatol:乌帕替尼（Upadacitinib）治疗中重度特应性皮炎的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa2b30103219)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264791, encodeId=ad651264e9147, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=Lancet：Garadacimab可有效预防C1酯酶抑制剂缺乏性遗传性血管性水肿患者的水肿发作, objectType=article, longId=299975, objectId=14d32999e546, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14d32999e546, replyNumber=0, likeNumber=42, createdTime=2022-03-04, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14d32999e546, moduleTitle=Lancet：Garadacimab可有效预防C1酯酶抑制剂缺乏性遗传性血管性水肿患者的水肿发作, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14d32999e546)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264790, encodeId=1f131264e901e, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=武田收购Adaptate Biotherapeutics，以开发针对实体瘤的新型Gamma Delta (γδ) T细胞衔接器疗法, objectType=article, longId=294032, objectId=36af294032f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36af294032f6, replyNumber=0, likeNumber=39, createdTime=2022-01-17, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36af294032f6, moduleTitle=武田收购Adaptate Biotherapeutics，以开发针对实体瘤的新型Gamma Delta (γδ) T细胞衔接器疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36af294032f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264789, encodeId=10af1264e89d4, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=Clin Cancer Res：Adavosertib联合各种化疗药治疗原发铂耐药的卵巢癌、输卵管癌、腹膜癌, objectType=article, longId=293566, objectId=93972935663a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93972935663a, replyNumber=0, likeNumber=47, createdTime=2022-01-09, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93972935663a, moduleTitle=Clin Cancer Res：Adavosertib联合各种化疗药治疗原发铂耐药的卵巢癌、输卵管癌、腹膜癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93972935663a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264788, encodeId=12dc1264e88c7, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=J Clin Oncol：WEE1抑制剂在TP53和RAS突变转移性结直肠癌中有效:一项比较Adavosertib (AZD1775)和主动监测的随机试验(FOCUS4-C), objectType=article, longId=291939, objectId=aea92919392a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aea92919392a, replyNumber=0, likeNumber=24, createdTime=2021-12-17, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aea92919392a, moduleTitle=J Clin Oncol：WEE1抑制剂在TP53和RAS突变转移性结直肠癌中有效:一项比较Adavosertib (AZD1775)和主动监测的随机试验(FOCUS4-C), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aea92919392a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264787, encodeId=06b11264e873c, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=Brugada综合征：传统认识与证据的更新, objectType=article, longId=291764, objectId=46ad291e6477, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46ad291e6477, replyNumber=0, likeNumber=57, createdTime=2021-12-15, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46ad291e6477, moduleTitle=Brugada综合征：传统认识与证据的更新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46ad291e6477)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264786, encodeId=5ffc1264e86df, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=Clin Cancer Res：Adavosertib联合化疗治疗铂耐药的卵巢癌、输卵管癌及腹膜癌的效果, objectType=article, longId=221499, objectId=28ce221499a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28ce221499a5, replyNumber=0, likeNumber=41, createdTime=2021-12-05, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28ce221499a5, moduleTitle=Clin Cancer Res：Adavosertib联合化疗治疗铂耐药的卵巢癌、输卵管癌及腹膜癌的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28ce221499a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264785, encodeId=a7f61264e85f2, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=J Thorac Oncol：ADAURA研究：IB-IIIA期EGFR突变阳性NSCLC切除术后使用奥希替尼辅助治疗改善患者DFS，无论是否接受辅助化疗, objectType=article, longId=220083, objectId=ae6a2200837d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae6a2200837d, replyNumber=0, likeNumber=38, createdTime=2021-11-12, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae6a2200837d, moduleTitle=J Thorac Oncol：ADAURA研究：IB-IIIA期EGFR突变阳性NSCLC切除术后使用奥希替尼辅助治疗改善患者DFS，无论是否接受辅助化疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae6a2200837d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264784, encodeId=af9a1264e84b7, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=Alz Res Therapy：ADAM10，可预测认知减退, objectType=article, longId=219823, objectId=62a3219823eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62a3219823eb, replyNumber=0, likeNumber=37, createdTime=2021-11-06, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62a3219823eb, moduleTitle=Alz Res Therapy：ADAM10，可预测认知减退, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62a3219823eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264783, encodeId=c2db1264e83ad, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=病例 | 抽丝剥茧，一例罕见的老年肺栓塞晕厥患者的Brugada样心电图, objectType=article, longId=218819, objectId=6bd6218819be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6bd6218819be, replyNumber=0, likeNumber=37, createdTime=2021-10-20, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6bd6218819be, moduleTitle=病例 | 抽丝剥茧，一例罕见的老年肺栓塞晕厥患者的Brugada样心电图, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6bd6218819be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264782, encodeId=11711264e8202, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=JNNP：7TPC-MRA评估CADASIL患者豆状动脉血流速度, objectType=article, longId=218281, objectId=160921828106, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=160921828106, replyNumber=0, likeNumber=31, createdTime=2021-10-10, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=160921828106, moduleTitle=JNNP：7TPC-MRA评估CADASIL患者豆状动脉血流速度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=160921828106)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264781, encodeId=dcfc1264e81b2, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=J Clin Oncol：WEE1抑制剂在TP53和RAS突变转移性结直肠癌中有效:一项比较Adavosertib (AZD1775)和主动监测的随机试验(FOCUS4-C), objectType=article, longId=217348, objectId=9f0d21e348f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f0d21e348f1, replyNumber=0, likeNumber=28, createdTime=2021-09-21, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f0d21e348f1, moduleTitle=J Clin Oncol：WEE1抑制剂在TP53和RAS突变转移性结直肠癌中有效:一项比较Adavosertib (AZD1775)和主动监测的随机试验(FOCUS4-C), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f0d21e348f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264780, encodeId=beff1264e802c, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=JADA：如何判断自己得了磨牙症，得了磨牙症应该怎么办？, objectType=article, longId=216510, objectId=720121651077, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=720121651077, replyNumber=0, likeNumber=28, createdTime=2021-09-02, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=720121651077, moduleTitle=JADA：如何判断自己得了磨牙症，得了磨牙症应该怎么办？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=720121651077)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264779, encodeId=97521264e79ff, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=JADA:催眠可作为口腔麻醉选择？, objectType=article, longId=216484, objectId=8e7021648478, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e7021648478, replyNumber=0, likeNumber=35, createdTime=2021-09-01, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e7021648478, moduleTitle=JADA:催眠可作为口腔麻醉选择？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e7021648478)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264778, encodeId=6cfa1264e78af, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=J Hematol Oncol：塞利尼索(selinexor)治疗复发/难治性弥漫大B淋巴细胞瘤的疗效：SADAL研究, objectType=article, longId=215018, objectId=3aeb21501886, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3aeb21501886, replyNumber=0, likeNumber=42, createdTime=2021-07-31, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3aeb21501886, moduleTitle=J Hematol Oncol：塞利尼索(selinexor)治疗复发/难治性弥漫大B淋巴细胞瘤的疗效：SADAL研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3aeb21501886)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ADA

2020-05-29

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

J Headache Pain：丛集性头痛的经济和个人负担

2022-05-31

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

J Headache Pain：头痛的全球患病率

2022-05-30

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

J Headache Pain：致残原因第二，令人炸裂的偏头痛！

2022-05-14

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

Alvotech和STADA与艾伯维解决欧洲专利纠纷，为Humira®的无柠檬酸盐、高浓度生物仿制药HUKYNDRA®(AVT02)上市铺平道路

2022-04-09

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

FDA拒绝批准vadadustat治疗CKD相关贫血

2022-04-05

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

JAMA Dermatol:乌帕替尼（Upadacitinib）治疗中重度特应性皮炎的疗效和安全性

2022-03-19

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

Lancet：Garadacimab可有效预防C1酯酶抑制剂缺乏性遗传性血管性水肿患者的水肿发作

2022-03-04

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

武田收购Adaptate Biotherapeutics，以开发针对实体瘤的新型Gamma Delta (γδ) T细胞衔接器疗法

2022-01-17

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

Clin Cancer Res：Adavosertib联合各种化疗药治疗原发铂耐药的卵巢癌、输卵管癌、腹膜癌

2022-01-09

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

J Clin Oncol：WEE1抑制剂在TP53和RAS突变转移性结直肠癌中有效:一项比较Adavosertib (AZD1775)和主动监测的随机试验(FOCUS4-C)

2021-12-17

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

Brugada综合征：传统认识与证据的更新

2021-12-15

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

Clin Cancer Res：Adavosertib联合化疗治疗铂耐药的卵巢癌、输卵管癌及腹膜癌的效果

2021-12-05

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

J Thorac Oncol：ADAURA研究：IB-IIIA期EGFR突变阳性NSCLC切除术后使用奥希替尼辅助治疗改善患者DFS，无论是否接受辅助化疗

2021-11-12

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

Alz Res Therapy：ADAM10，可预测认知减退

2021-11-06

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

病例 | 抽丝剥茧，一例罕见的老年肺栓塞晕厥患者的Brugada样心电图

2021-10-20

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

JNNP：7TPC-MRA评估CADASIL患者豆状动脉血流速度

2021-10-10

仁者大医 (审核中...)

前往app查看评论内容

#ADA#

J Clin Oncol：WEE1抑制剂在TP53和RAS突变转移性结直肠癌中有效:一项比较Adavosertib (AZD1775)和主动监测的随机试验(FOCUS4-C)

2021-09-21

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

JADA：如何判断自己得了磨牙症，得了磨牙症应该怎么办？

2021-09-02

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

JADA:催眠可作为口腔麻醉选择？

2021-09-01

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

J Hematol Oncol：塞利尼索(selinexor)治疗复发/难治性弥漫大B淋巴细胞瘤的疗效：SADAL研究

2021-07-31

科室
- - 订阅+
  - 更多科室
工具
服务